<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[International Journal of Ophthalmology Press -->COVID-19 and Ophthalmology]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Standard precaution measurements during ophthalmology practice in the pandemic stage of COVID-19]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200701]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To take specific precautions and keep a safe practice during providing ophthalmology health services without compromising the patient’s safety as well as the team workers and the community in the pandemic stage of corona virus disease 2019 (COVID-19).
METHODS: Applying patient circulation scheme implemented in our ophthalmology centers with the guidance of ministry of health infection control guidelines started from the moment that we receive a call or WhatsApp message or Facebook inquiry from patients until 21d after patients first visit if any. Four directions were taken. First, community awareness of the disease and the ophthalmology related advices in how eye can transfers the infection and how to protect our eyes not to be infected through videos interviews of our consultants and distribution in social media like Instagram, Facebook, WhatsApp pages radio and TV interviews as well as leaflet health awareness for distribution for public. Second, scheduling of patients’ appointments to prevent overcrowdings and cross infection. Third, protective measurements tools in the center to detect and prevent any exposure of the patients to patients and to protect medical staff, COVID-19 scoring system was set up to identify patients with fever, respiratory symptoms, acute conjunctivitis or recent travel to outbreak areas and to encourage these individuals to postpone their appointments for at least 21d. Proper use of personal protective equipment was implemented. Stopping all the elective surgeries keeping only the emergency types advised by fourth: how to deal with our patients if they need an urgent ophthalmological intervention and how to deal with suspected cases of corona if any cases detected.
RESULTS: Our measures helped our colleagues to try to keep providing ophthalmology health services without increasing the incidence of infection for COVID-19 until this pandemic is over.
CONCLUSION: In our practice, ophthalmologists should work with new aura of social media to facilitate the non-direct communication with the patients through maximizing the use of communication technology to keep contact with their patients and deal safely with COVID-19 cases.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Ahmed Mohamed Reda and Wael M. Ahmed]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmed Mohamed Reda and Wael M. Ahmed</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200701]]></guid><cfi:id>11</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ophthalmology in the time of COVID-19: experience from Hong Kong Eye Hospital]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200601]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To review international guidelines and to share our infection control experience during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary eye centre in Hong Kong.
METHODS: Infection control guidelines and recommendations from international ophthalmological bodies are reviewed and discussed. The measures at our hospital were drawn up as per international and local health authorities’ guidelines and implemented with the collaboration of doctors, nurses and administrative staff.
RESULTS: The aims of our infection control measures are to 1) minimize cross-infection within the hospital; 2) protect and support hospital staff; 3) ensure environmental control. To minimize the risk of cross-infection, outpatient attendance and elective surgery have been reduced by 40%, and general anesthesia procedures were reduced by 90%. Patients entering the hospital are screened for fever, travel history, contact and cluster history, and COVID-19 related symptoms. To protect and support hospital staff, we ensure provision of adequate personal protective equipment (PPE) and provide clear guidelines on the level of PPE needed, depending on the clinical situation. Other protective measures include provision of work uniforms, easy access to alcohol-based hand rub, opening new lunch areas, implementation of self-monitoring and self-reporting systems, and communication via online education and updates. Finally, environmental control is achieved by ensuring regular disinfection of the hospital premise, enhancing ventilation, and usage of disposable ophthalmic instruments.
CONCLUSION: Our multi-pronged approach to infection control is, so far, successful in minimizing infection risks, while allowing the maintenance of essential ophthalmic services.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Stephanie S.L. Cheung, Cherie Y.K. Wong, Jason C.K. Chan, Carmen K.M. Chan, N.M. Lam, Hunter K.L. Yuen, Victoria W.Y. Wong, Chi Wai Tsang and Clement C.Y. Tham]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Stephanie S.L. Cheung, Cherie Y.K. Wong, Jason C.K. Chan, Carmen K.M. Chan, N.M. Lam, Hunter K.L. Yuen, Victoria W.Y. Wong, Chi Wai Tsang and Clement C.Y. Tham</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200601]]></guid><cfi:id>10</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular manifestations and SARS-CoV-2 detection in tears and conjunctival scrape from non-severe COVID-19 patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210801]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the ocular features of corona virus disease (COVID)-19 and severe acute respiratory syndrome coronavirus (SARS-CoV)-2 detection in tears and conjunctival scrapes in non-severe COVID-19 patients.
METHODS: This is a multicenter observational clinical study with no intervention conducted from Jan 25th to March 1st, 2020. Clinical data and samples of tears and conjunctival scraping were collected in consecutive laboratory-confirmed, non-severe COVID-19 patients from three hospitals. COVID-19 virus was analyzed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) kits.
RESULTS: Totally 255 laboratory-confirmed, non-severe COVID-19 patients were recruited for ocular manifestation investigation. Of them, 54.9% were females, with a mean age of 49.4y. None of the patients has evidence of uveitis; 11 patients (4.3%) complained of mild asthenopia; 2 (0.8%) had mild conjunctival congestion and serous secretion. Twenty-five of them had performed tears and conjunctival scrape for COVID-19 virus detection, with 4 yield possible positive results in the nucleoprotein gene. One of them were asymptomatic with normal chest CT and positive pharyngeal swab result.
CONCLUSION: Ocular manifestations are neither common nor specific in non-severe COVID-19 patients. Meanwhile, COVID-19 virus nucleotides can be detected in the tears and conjunctival scrape samples, warranting further research on the transmissibility by the ocular route.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Bing Jiang, Shao-Jie Li, Wen-Long Wang, Min Hu, Sui He, Jian Cao, Li Jiang and Yun Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bing Jiang, Shao-Jie Li, Wen-Long Wang, Min Hu, Sui He, Jian Cao, Li Jiang and Yun Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210801]]></guid><cfi:id>9</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ophthalmic practice during COVID-19 pandemic]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210501]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Coronavirus disease 2019 (COVID-19) pandemic has caused significant changes in ophthalmic practice. The initial strategy of strict restriction of elective activities has been replaced with various guidelines to revitalize ophthalmic procedures considering the new safety concerns. In this manuscript, we reviewed recent recommendations for ophthalmic practice in different fields of ophthalmology during the COVID-19 pandemic.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Mohammad Soleimani, Mohammad Mehrpour and Hossein Mohammad-Rabei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Soleimani, Mohammad Mehrpour and Hossein Mohammad-Rabei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210501]]></guid><cfi:id>8</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Response of L V Prasad Eye Institute to COVID-19 outbreak in India: experience at its tertiary eye care centre and adoption to its Eye Health Pyramid]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210101]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To summarize the experience of response to COVID-19 outbreak at a tertiary eye care institute and its network of health facilities in India.
METHODS: Our responses are based on the principles of social distancing, hand hygiene, respiratory etiquettes, surface disinfection protocol, and rational use of appropriate personal protective equipment (PPE). We describe our response in terms of administrative controls, clinical protocols, staff protection, environmental controls, and social distancing measures. We also discuss our communication strategies and monitoring systems, to ensure compliance to protocols.
RESULTS: Administrative control is mainly related to formation of task force and its functions. Clinical protocols are related to patient triaging methods and clinical examination guidelines in Outpatient, Inpatient and Operating Room. Staff protection is focused on training staff on the protocols to be followed in hospital as well as at home, and use of PPE. Environmental protocol is focused on cleaning and disinfectant methods to be used in the hospital. In addition, there are systems for communication as well as monitoring compliance to protocols.
CONCLUSION: We hope that these protocols and our experience would help the ophthalmic community globally and serve as a guide to protect ophthalmologists and ophthalmic care personnel, and their patients across the world.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Rohit C Khanna, Prashant Garg, Pravin K Vaddavalli, Merle Fernandes, Suryasnata Rath, Sameera Nayak, Raja Narayanan, Rajeev Reddy Pappuru, Swathi Kaliki, Anthony Vipin Das, Savitri Sharma and Subhadra Jalali]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rohit C Khanna, Prashant Garg, Pravin K Vaddavalli, Merle Fernandes, Suryasnata Rath, Sameera Nayak, Raja Narayanan, Rajeev Reddy Pappuru, Swathi Kaliki, Anthony Vipin Das, Savitri Sharma and Subhadra Jalali</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210101]]></guid><cfi:id>7</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcome of orbital apex syndrome in COVID associated mucormycosis patients in a tertiary care hospital]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220401]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To share clinical pattern of presentation, the modalities of surgical intervention and the one month post-surgical outcome of rhino-orbito-mucormycosis (ROCM) cases.METHODS: All COVID associated mucormycosis (CAM) patients underwent comprehensive multidisciplinary examination by ophthalmologist, otorhinolaryngologist and physician. Patients with clinical and radiological evidence of orbital apex involvement were included in the study. Appropriate medical and surgical intervention were done to each patient. Patients were followed up one-month post intervention.RESULTS: Out of 89 CAM patients, 31 (34.8%) had orbital apex syndrome. Sixty-six (74.2%) of such patients had pre-existing diabetes mellitus, 18 (58%) patients had prior documented use of steroid use, and 55 (61.8%) had no light perception (LP) presenting vision. Blepharoptosis, proptosis, complete ophthalmoplegia were common clinical findings. Seventeen (19.1%) of such patients had variable amount of cavernous sinus involvement. Endoscopic debridement of paranasal sinuses and orbit with or without eyelid sparing limited orbital exenteration was done in most cases, 34 (38.2%) patients could retain vision in the affected eye.CONCLUSION: Orbital apex involvement in CAM patients occur very fast. It not only leads to loss of vision but also sacrifice of the eyeball, orbital contents and eyelids. Early diagnosis and prompt intervention can preserve life, vision and spare mutilating surgeries.]]></description>
<pubDate>2022/3/29 14:34:11</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Smiti Rani Srivastava, Purban Ganguly, Debasis Barman, Sudip Das, Manimoy Bandyopadhyay, Asim Kumar Ghosh, Subhra Sarkar, Amitabha Sengupta, Sarbari Swaika, Pritam Chatterjee, Amit Kumar Gupta, Alok Ranjan Mondal, Soumyajit Guha, Sinjita Dutta, Souvik Adhikari, Aditi Kaushik, Partha Sundar Biswas and Asif Ayub]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Smiti Rani Srivastava, Purban Ganguly, Debasis Barman, Sudip Das, Manimoy Bandyopadhyay, Asim Kumar Ghosh, Subhra Sarkar, Amitabha Sengupta, Sarbari Swaika, Pritam Chatterjee, Amit Kumar Gupta, Alok Ranjan Mondal, Soumyajit Guha, Sinjita Dutta, Souvik Adhikari, Aditi Kaushik, Partha Sundar Biswas and Asif Ayub</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220401]]></guid><cfi:id>6</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of baffle and intraocular pressure on aerosols generated in the noncontact tonometer measurement during COVID-19]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220402]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of baffle and intraocular pressure (IOP) on the aerosols generated in the noncontact tonometer (NCT) measurement and provide recommendations for the standardized use of the NCT during coronavirus disease 2019 (COVID-19).METHODS: This clinical trial included 252 subjects (312 eyes) in The Eye Hospital, Wenzhou Medical University from March 7, 2020, to March 28, 2020. Sixty subjects (120 eyes) with normal IOP were divided into two groups. One group used an NCT without a baffle, another group used an NCT with a baffle. Another 192 subjects (192 eyes) were divided into four groups: Group A1 (without a baffle+normal IOP), Group A2 (without a baffle+high IOP), Group B1 (with a baffle+normal IOP) and Group B2 (with a baffle+high IOP). Particulate matter (PM) 2.5 and PM10 generated by all subjects were quantified during the NCT measurement. The IOP values were recorded simultaneously. Effects of baffle and IOP on aerosols generated during the NCT measurement were analyzed.RESULTS: In the normal eye group with a baffle, the aerosol density decreased in a wave-like shape near the NCT with the increase in the number of people measured for IOP, demonstrating no cumulative effect. However, in the normal eye group without a baffle, there was a cumulative effect. PM2.5 and PM10 in Group A2 were higher than Group A1 (both P<0.001). The PM2.5 and PM10 in Group B2 were higher than Group B1 (P<0.01, P<0.001 respectively). The PM10 of Group B1 was lower than Group A1 (P<0.01). PM2.5 in Group B2 were lower than Group A2 (P<0.01). The median of per capita PM2.5 and PM10 in the combined Group A1+A2 were 0.80 and 1.10 μg/m3 respectively, which were higher than 0.20 and 0.60 μg/m3 in the combined Group B1+B2 (both P<0.01). The median of per capita PM2.5 and PM10 in the combined Group A1+B1 were 0.10 and 0.20 μg/m3 respectively, which were lower than 1.30 and 1.70 μg/m3 in the combined Group A2+B2 (both P<0.001).CONCLUSION: More aerosols could be generated in patients with high IOP. After the NCT is equipped with a baffle, per capita aerosol density generated decreased significantly near the NCT; And with the increase in the number of people measured for IOP, the aerosols gradually dissipated near the NCT, demonstrating no cumulative effect. Therefore, it is suggested that the NCT should be equipped with a baffle, especially for patients with high IOP.]]></description>
<pubDate>2022/3/29 14:34:12</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Yuan Tang, Yan-Yan Chen, Chun-Chun Li, Zhang-Yan Chen, Chen Chen, Si-Qi Wen, Xiao-Qiong Huang, Jia Qu, Yan-Miao Chen and Ai-Ai Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan Tang, Yan-Yan Chen, Chun-Chun Li, Zhang-Yan Chen, Chen Chen, Si-Qi Wen, Xiao-Qiong Huang, Jia Qu, Yan-Miao Chen and Ai-Ai Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220402]]></guid><cfi:id>5</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of knowledge, perception, and practice patterns of Jordanian optometrists during COVID-19 pandemic: a cross-sectional online survey]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221101]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate knowledge, risk perception, and attitude towards corona virus disease 2019 (COVID-19) and infection control measures among optometrists in Jordan.METHODS: A cross-sectional survey was distributed through social media platforms to optometrists registered with the Jordanian syndicate and Jordanian association of optics. Information on participants’ socio-demographic characteristics, knowledge of clinical features of COVID-19, risk assessment and infection control measures for preventing disease transmission were collected.RESULTS: A total of 135 optometrists (80 females and 55 males) with a mean age of 32±10y responded to the survey. Most optometrists were aware of COVID-19 symptoms, modes of transmission and measures for preventing COVID-19 and transmission in the ophthalmic setup. However, more than half of the optometrists did not receive any training about protection or infection control by their employers at their work place. Social media was the most common source of information on COVID-19 (76%). Most optometrists (85.2%) thought that the virus could be detected in tears, and 45.9% thought that red eye is a symptom of COVID-19.CONCLUSION: Optometrists in Jordan are aware of the clinical features and preventive measures related to COVID-19 infection. However, training on infection control is lacking and needs to be improved. Guidelines by international professional optometric associations should be promoted through regional and national associations to all registered optometrists and access to peer review. Journals should be encouraged to ensure that the knowledge about the pandemic is up to date and accurate.]]></description>
<pubDate>2022/10/25 14:09:31</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Mera F. Haddad and Yousef Khader]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mera F. Haddad and Yousef Khader</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221101]]></guid><cfi:id>4</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual perception alterations in COVID-19: a preliminary study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230101]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the visual perception (color and chromatic-achromatic contrast vision) of a small cohort of COVID-19 patients at the time of infection and after 6mo with that of a healthy population matched for sex and age.METHODS: A total of 25 patients (9 females, 16 males, mean age: 54±10y) with COVID-19 hospitalized in the COVID-19 Unit of the University Clinical Hospital of Valladolid were recruited for this preliminary study. Visual perception, as determined by monocular measurement of contrast sensitivity function (CSF) and color vision was assessed in each patient using the Optopad test. The results obtained were then compared with those of a sample of 16 age- and sex-matched healthy controls (5 females, 11 males, mean age: 50±6y) in which the same measurement procedure was repeated. Statistically significant differences between groups were assessed using the Mann-Whitney U test. Measurements were repeated after a minimum follow-up period of 6mo and statistically significant differences between the two time points in each group were assessed using the Wilcoxon signed rank test.RESULTS: Discrimination thresholds (color and chromatic-achromatic contrast vision) and their corresponding sensitivity, calculated as the inverse of the discrimination threshold, were evaluated. Analysis of the data revealed higher contrast threshold results (i.e., worse contrast sensitivity) in the COVID-19 group than in the control group for all spatial frequencies studied in the Optopad-CSF achromatic test and most of the spatial frequencies studied in the Optopad-CSF chromatic test for the red-green and blue-yellow mechanisms. In addition, color threshold results in the COVID-19 group were also significantly higher (i.e., worse color sensitivity) for almost all color mechanisms studied in the Optopad-Color test. At 6mo, most of the differences found between the groups were maintained despite COVID-19 recovery.CONCLUSION: The present results provide preliminary evidence that visual perception may be impaired in COVID-19, even when the infection has passed. Although further research is needed to determine the precise causes of this finding, analysis of CSF and color vision could provide valuable information on the visual impact of COVID-19.]]></description>
<pubDate>2022/12/23 15:16:41</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[María Begona Coco-Martín, Luis Leal-Vega, Irene Alcoceba-Herrero, Ainhoa Molina-Martín, Dolores de-Fez, María José Luque, Carlos Duenas-Gutiérrez, Juan Francisco Arenillas-Lara and David P. Pinero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>María Begona Coco-Martín, Luis Leal-Vega, Irene Alcoceba-Herrero, Ainhoa Molina-Martín, Dolores de-Fez, María José Luque, Carlos Duenas-Gutiérrez, Juan Francisco Arenillas-Lara and David P. Pinero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230101]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of ocular trauma between normalized and the COVID-19 epidemic periods in China: a multi-center cross-sectional study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230102]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the feature of ocular trauma between normalized period and the COVID-19 epidemic period in China, and to provide a profile for eye injuries in special times in future.METHODS: This is a multi-center cross-sectional study with 30 participated hospitals involving the China Ocular Trauma Society members. All hospitalized cases who visited the Ophthalmology Department in participated hospitals with eye injuries during the normalized period (2019) and the COVID-19 epidemic period (2020) were included in this study. Demographic characteristic of cases, date of injury, sites and types of injury were collected.RESULTS: This study involved 13 525 (61 cases with both eyes) injured cases. There were 7269 (53.74%) eye-injured cases and 6256 (46.26%) eye-injured cases in 2019 and 2020 separately. Compared with 2019, the incidence of ocular trauma in retirees, housewives and unemployed increased with year-on-year of 4.96%, 102.67%, and 11.64% among all occupations. In 2020, the incidence of eye injuries decreased in all injury sites except for an increase in home (30.29% year-on-year). The incidence of mechanical eye injuries decreased, while that of non-mechanical eye injuries (chemical/thermal/radiation) increased (47.45% year-on-year). There were 255 (3.51%, 255/7269) and 376 (6.01%, 376/6256) non-mechanical injured cases in 2019 and 2020 (Pearson Chi2=47.33, P<0.001) separately.CONCLUSION: During the COVID-19 epidemic period, the total cases of ocular trauma decrease but the proportion of non-mechanical ocular trauma increase. Penetrating is still the highest proportion among all types of mechanical ocular trauma. From a preventive point of view, protection for retired persons, housewives and unemployed persons should be improved during public health events period.]]></description>
<pubDate>2022/12/23 15:16:42</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[Ya-Xin Zhang, Kang Feng, Meng-Yu Liao and Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Xin Zhang, Kang Feng, Meng-Yu Liao and Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230102]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[COVID-19 pandemic impact on ocular trauma in a tertiary hospital]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230103]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the impact of the coronavirus disease- 2019 (COVID-19) pandemic on the presentation and characteristics of patients hospitalized for ocular trauma in a tertiary hospital in China between 2019 and 2020.METHODS: A retrospective case study was designed to collect information on all cases of ocular trauma in a tertiary hospital from 2019 to 2020 and compare differences in inpatients’ data (age, sex, admission vision acuity, type of diagnosis, hospital stays, mechanism of injury and location of injury).RESULTS: The total number of patients admitted to the Ophthalmology Department was 883 (mean 73.58±11.25 patients per month) in 2019 and 714 (59.50±17.92 patients per month) in 2020. The injury number of in work was also the most within the four types of location in this two year (42.36% in 2019, 43.84% in 2020). The mean hospital stays were 12.66d in 2019 and 10.81d in 2020. The highest incidence of ocular trauma was the middle-aged (41-65y) groups in 2019 and 2020. The most common cause of ocular trauma was sharp object in 2019 (47.34%) and 2020 (47.58%). The mechanical ocular trauma reaches 98.98% in 2019 and 99.72% in 2020.CONCLUSION: The number of patients with ocular trauma decreased in 2020, but middle-aged (41-65y) are still high incident groups. Mechanical ocular trauma remains the leading cause of hospitalization for ocular trauma patients and the proportion of patients injured at home increases. It is necessary to arouse social attention and the public’s awareness of eye trauma protection should be strengthened during the pandemic.]]></description>
<pubDate>2022/12/23 15:16:42</pubDate>
<category><![CDATA[COVID-19 and Ophthalmology]]></category>
<author><![CDATA[You-Mei Xu, Li-Ping Du, Ya-Dan Huo, Guang-Qi An, Xue-Min Jin and Peng-Yi Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>You-Mei Xu, Li-Ping Du, Ya-Dan Huo, Guang-Qi An, Xue-Min Jin and Peng-Yi Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230103]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>